 | • レポートコード：MRC2-11QY09403 • 出版社/出版日：QYResearch / 2020年11月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥561,600 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥842,400 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,123,200 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は性機能障害治療薬のグローバル市場について調査・分析したレポートです。種類別（経口療法、鼻腔内療法、ホルモン療法、経尿道的療法）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別性機能障害治療薬の競争状況、市場シェア ・世界の性機能障害治療薬市場：種類別市場規模 2015年-2020年（経口療法、鼻腔内療法、ホルモン療法、経尿道的療法） ・世界の性機能障害治療薬市場：種類別市場規模予測 2021年-2026年（経口療法、鼻腔内療法、ホルモン療法、経尿道的療法） ・世界の性機能障害治療薬市場：用途別市場規模 2015年-2020年（男性、女性） ・世界の性機能障害治療薬市場：用途別市場規模予測 2021年-2026年（男性、女性） ・北米の性機能障害治療薬市場分析：米国、カナダ ・ヨーロッパの性機能障害治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの性機能障害治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の性機能障害治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの性機能障害治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、GlaxoSmithKline、Merck、Eli Lilly、AbbVie、Bayer、Teva Pharmaceutical Industries、Takeda、Apricus Biosciences、Emotional Brain、Ivix LLX、Leadiant Biosciences、NexMed、S1 Biopharma、Vietstar Biomedical Research ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.
Market Analysis and Insights: Global Sexual Dysfunction Drugs Market
The global Sexual Dysfunction Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sexual Dysfunction Drugs Scope and Market Size
Sexual Dysfunction Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sexual Dysfunction Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Sexual Dysfunction Drugs market is segmented into
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Segment by Application, the Sexual Dysfunction Drugs market is segmented into
Male
Female
Regional and Country-level Analysis
The Sexual Dysfunction Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sexual Dysfunction Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sexual Dysfunction Drugs Market Share Analysis
Sexual Dysfunction Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sexual Dysfunction Drugs business, the date to enter into the Sexual Dysfunction Drugs market, Sexual Dysfunction Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
1 Study Coverage
1.1 Sexual Dysfunction Drugs Product Introduction
1.2 Market Segments
1.3 Key Sexual Dysfunction Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sexual Dysfunction Drugs Market Size Growth Rate by Type
1.4.2 Oral Therapy
1.4.3 Intracavernosal Therapy
1.4.4 Hormonal Therapy
1.4.5 Transurethral Therapy
1.5 Market by Application
1.5.1 Global Sexual Dysfunction Drugs Market Size Growth Rate by Application
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Sexual Dysfunction Drugs Market Size, Estimates and Forecasts
2.1.1 Global Sexual Dysfunction Drugs Revenue 2015-2026
2.1.2 Global Sexual Dysfunction Drugs Sales 2015-2026
2.2 Global Sexual Dysfunction Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Sexual Dysfunction Drugs Competitor Landscape by Players
3.1 Sexual Dysfunction Drugs Sales by Manufacturers
3.1.1 Sexual Dysfunction Drugs Sales by Manufacturers (2015-2020)
3.1.2 Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Sexual Dysfunction Drugs Revenue by Manufacturers
3.2.1 Sexual Dysfunction Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Sexual Dysfunction Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sexual Dysfunction Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sexual Dysfunction Drugs Revenue in 2019
3.2.5 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sexual Dysfunction Drugs Price by Manufacturers
3.4 Sexual Dysfunction Drugs Manufacturing Base Distribution, Product Types
3.4.1 Sexual Dysfunction Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sexual Dysfunction Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Sexual Dysfunction Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sexual Dysfunction Drugs Market Size by Type (2015-2020)
4.1.1 Global Sexual Dysfunction Drugs Sales by Type (2015-2020)
4.1.2 Global Sexual Dysfunction Drugs Revenue by Type (2015-2020)
4.1.3 Sexual Dysfunction Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sexual Dysfunction Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Sexual Dysfunction Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Sexual Dysfunction Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Sexual Dysfunction Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sexual Dysfunction Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Sexual Dysfunction Drugs Market Size by Application (2015-2020)
5.1.1 Global Sexual Dysfunction Drugs Sales by Application (2015-2020)
5.1.2 Global Sexual Dysfunction Drugs Revenue by Application (2015-2020)
5.1.3 Sexual Dysfunction Drugs Price by Application (2015-2020)
5.2 Sexual Dysfunction Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Sexual Dysfunction Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Sexual Dysfunction Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Sexual Dysfunction Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Sexual Dysfunction Drugs by Country
6.1.1 North America Sexual Dysfunction Drugs Sales by Country
6.1.2 North America Sexual Dysfunction Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sexual Dysfunction Drugs Market Facts & Figures by Type
6.3 North America Sexual Dysfunction Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Sexual Dysfunction Drugs by Country
7.1.1 Europe Sexual Dysfunction Drugs Sales by Country
7.1.2 Europe Sexual Dysfunction Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sexual Dysfunction Drugs Market Facts & Figures by Type
7.3 Europe Sexual Dysfunction Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Sexual Dysfunction Drugs by Region
8.1.1 Asia Pacific Sexual Dysfunction Drugs Sales by Region
8.1.2 Asia Pacific Sexual Dysfunction Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Type
8.3 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Sexual Dysfunction Drugs by Country
9.1.1 Latin America Sexual Dysfunction Drugs Sales by Country
9.1.2 Latin America Sexual Dysfunction Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sexual Dysfunction Drugs Market Facts & Figures by Type
9.3 Central & South America Sexual Dysfunction Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Sexual Dysfunction Drugs by Country
10.1.1 Middle East and Africa Sexual Dysfunction Drugs Sales by Country
10.1.2 Middle East and Africa Sexual Dysfunction Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Sexual Dysfunction Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Sexual Dysfunction Drugs Products Offered
11.3.5 Merck Related Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Description and Business Overview
11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly Sexual Dysfunction Drugs Products Offered
11.4.5 Eli Lilly Related Developments
11.5 AbbVie
11.5.1 AbbVie Corporation Information
11.5.2 AbbVie Description and Business Overview
11.5.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AbbVie Sexual Dysfunction Drugs Products Offered
11.5.5 AbbVie Related Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Description and Business Overview
11.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer Sexual Dysfunction Drugs Products Offered
11.6.5 Bayer Related Developments
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Corporation Information
11.7.2 Teva Pharmaceutical Industries Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Products Offered
11.7.5 Teva Pharmaceutical Industries Related Developments
11.8 Takeda
11.8.1 Takeda Corporation Information
11.8.2 Takeda Description and Business Overview
11.8.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Takeda Sexual Dysfunction Drugs Products Offered
11.8.5 Takeda Related Developments
11.9 Apricus Biosciences
11.9.1 Apricus Biosciences Corporation Information
11.9.2 Apricus Biosciences Description and Business Overview
11.9.3 Apricus Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Apricus Biosciences Sexual Dysfunction Drugs Products Offered
11.9.5 Apricus Biosciences Related Developments
11.10 Emotional Brain
11.10.1 Emotional Brain Corporation Information
11.10.2 Emotional Brain Description and Business Overview
11.10.3 Emotional Brain Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Emotional Brain Sexual Dysfunction Drugs Products Offered
11.10.5 Emotional Brain Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Sexual Dysfunction Drugs Products Offered
11.1.5 Pfizer Related Developments
11.12 Leadiant Biosciences
11.12.1 Leadiant Biosciences Corporation Information
11.12.2 Leadiant Biosciences Description and Business Overview
11.12.3 Leadiant Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Leadiant Biosciences Products Offered
11.12.5 Leadiant Biosciences Related Developments
11.13 NexMed
11.13.1 NexMed Corporation Information
11.13.2 NexMed Description and Business Overview
11.13.3 NexMed Sales, Revenue and Gross Margin (2015-2020)
11.13.4 NexMed Products Offered
11.13.5 NexMed Related Developments
11.14 S1 Biopharma
11.14.1 S1 Biopharma Corporation Information
11.14.2 S1 Biopharma Description and Business Overview
11.14.3 S1 Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 S1 Biopharma Products Offered
11.14.5 S1 Biopharma Related Developments
11.15 Vietstar Biomedical Research
11.15.1 Vietstar Biomedical Research Corporation Information
11.15.2 Vietstar Biomedical Research Description and Business Overview
11.15.3 Vietstar Biomedical Research Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Vietstar Biomedical Research Products Offered
11.15.5 Vietstar Biomedical Research Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sexual Dysfunction Drugs Market Estimates and Projections by Region
12.1.1 Global Sexual Dysfunction Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Sexual Dysfunction Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Sexual Dysfunction Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Sexual Dysfunction Drugs Sales Forecast (2021-2026)
12.2.2 North America: Sexual Dysfunction Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Sexual Dysfunction Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Sexual Dysfunction Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Sexual Dysfunction Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Sexual Dysfunction Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Sexual Dysfunction Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sexual Dysfunction Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sexual Dysfunction Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sexual Dysfunction Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sexual Dysfunction Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Sexual Dysfunction Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Sexual Dysfunction Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Sexual Dysfunction Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Sexual Dysfunction Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sexual Dysfunction Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sexual Dysfunction Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sexual Dysfunction Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sexual Dysfunction Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sexual Dysfunction Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sexual Dysfunction Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Sexual Dysfunction Drugs Market Segments
Table 2. Ranking of Global Top Sexual Dysfunction Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sexual Dysfunction Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Oral Therapy
Table 5. Major Manufacturers of Intracavernosal Therapy
Table 6. Major Manufacturers of Hormonal Therapy
Table 7. Major Manufacturers of Transurethral Therapy
Table 8. Global Sexual Dysfunction Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Sexual Dysfunction Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Sexual Dysfunction Drugs Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Sexual Dysfunction Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Sexual Dysfunction Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Sexual Dysfunction Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Sexual Dysfunction Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexual Dysfunction Drugs as of 2019)
Table 17. Sexual Dysfunction Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Sexual Dysfunction Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Sexual Dysfunction Drugs Price (2015-2020) (USD/Pcs)
Table 20. Sexual Dysfunction Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Sexual Dysfunction Drugs Product Type
Table 22. Date of International Manufacturers Enter into Sexual Dysfunction Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 25. Global Sexual Dysfunction Drugs Sales Share by Type (2015-2020)
Table 26. Global Sexual Dysfunction Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Sexual Dysfunction Drugs Revenue Share by Type (2015-2020)
Table 28. Sexual Dysfunction Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 30. Global Sexual Dysfunction Drugs Sales Share by Application (2015-2020)
Table 31. North America Sexual Dysfunction Drugs Sales by Country (2015-2020) (K Pcs)
Table 32. North America Sexual Dysfunction Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Sexual Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Sexual Dysfunction Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 36. North America Sexual Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 38. North America Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Sexual Dysfunction Drugs Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Sexual Dysfunction Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Sexual Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Sexual Dysfunction Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Sexual Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Sexual Dysfunction Drugs Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Sexual Dysfunction Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Sexual Dysfunction Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Sexual Dysfunction Drugs Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Sexual Dysfunction Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Sexual Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Sexual Dysfunction Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Sexual Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Sexual Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Sexual Dysfunction Drugs Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Sexual Dysfunction Drugs Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. GlaxoSmithKline Corporation Information
Table 77. GlaxoSmithKline Description and Major Businesses
Table 78. GlaxoSmithKline Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. GlaxoSmithKline Product
Table 80. GlaxoSmithKline Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Eli Lilly Corporation Information
Table 87. Eli Lilly Description and Major Businesses
Table 88. Eli Lilly Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Eli Lilly Product
Table 90. Eli Lilly Recent Development
Table 91. AbbVie Corporation Information
Table 92. AbbVie Description and Major Businesses
Table 93. AbbVie Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. AbbVie Product
Table 95. AbbVie Recent Development
Table 96. Bayer Corporation Information
Table 97. Bayer Description and Major Businesses
Table 98. Bayer Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Bayer Product
Table 100. Bayer Recent Development
Table 101. Teva Pharmaceutical Industries Corporation Information
Table 102. Teva Pharmaceutical Industries Description and Major Businesses
Table 103. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Teva Pharmaceutical Industries Product
Table 105. Teva Pharmaceutical Industries Recent Development
Table 106. Takeda Corporation Information
Table 107. Takeda Description and Major Businesses
Table 108. Takeda Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Takeda Product
Table 110. Takeda Recent Development
Table 111. Apricus Biosciences Corporation Information
Table 112. Apricus Biosciences Description and Major Businesses
Table 113. Apricus Biosciences Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Apricus Biosciences Product
Table 115. Apricus Biosciences Recent Development
Table 116. Emotional Brain Corporation Information
Table 117. Emotional Brain Description and Major Businesses
Table 118. Emotional Brain Sexual Dysfunction Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Emotional Brain Product
Table 120. Emotional Brain Recent Development
Table 121. Ivix LLX Corporation Information
Table 122. Ivix LLX Description and Major Businesses
Table 123. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Ivix LLX Product
Table 125. Ivix LLX Recent Development
Table 126. Leadiant Biosciences Corporation Information
Table 127. Leadiant Biosciences Description and Major Businesses
Table 128. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. Leadiant Biosciences Product
Table 130. Leadiant Biosciences Recent Development
Table 131. NexMed Corporation Information
Table 132. NexMed Description and Major Businesses
Table 133. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. NexMed Product
Table 135. NexMed Recent Development
Table 136. S1 Biopharma Corporation Information
Table 137. S1 Biopharma Description and Major Businesses
Table 138. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 139. S1 Biopharma Product
Table 140. S1 Biopharma Recent Development
Table 141. Vietstar Biomedical Research Corporation Information
Table 142. Vietstar Biomedical Research Description and Major Businesses
Table 143. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 144. Vietstar Biomedical Research Product
Table 145. Vietstar Biomedical Research Recent Development
Table 146. Global Sexual Dysfunction Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 147. Global Sexual Dysfunction Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 148. Global Sexual Dysfunction Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 149. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 150. North America: Sexual Dysfunction Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 151. North America: Sexual Dysfunction Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Europe: Sexual Dysfunction Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Europe: Sexual Dysfunction Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Asia Pacific: Sexual Dysfunction Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 155. Asia Pacific: Sexual Dysfunction Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 156. Latin America: Sexual Dysfunction Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 157. Latin America: Sexual Dysfunction Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Middle East and Africa: Sexual Dysfunction Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 159. Middle East and Africa: Sexual Dysfunction Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 161. Key Challenges
Table 162. Market Risks
Table 163. Main Points Interviewed from Key Sexual Dysfunction Drugs Players
Table 164. Sexual Dysfunction Drugs Customers List
Table 165. Sexual Dysfunction Drugs Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Sexual Dysfunction Drugs Product Picture
Figure 2. Global Sexual Dysfunction Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Therapy Product Picture
Figure 4. Intracavernosal Therapy Product Picture
Figure 5. Hormonal Therapy Product Picture
Figure 6. Transurethral Therapy Product Picture
Figure 7. Global Sexual Dysfunction Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Male
Figure 9. Female
Figure 10. Sexual Dysfunction Drugs Report Years Considered
Figure 11. Global Sexual Dysfunction Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Sexual Dysfunction Drugs Sales 2015-2026 (K Pcs)
Figure 13. Global Sexual Dysfunction Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Sexual Dysfunction Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Sexual Dysfunction Drugs Sales Market Share by Region in 2019
Figure 16. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Sexual Dysfunction Drugs Revenue Market Share by Region in 2019
Figure 18. Global Sexual Dysfunction Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Sexual Dysfunction Drugs Revenue in 2019
Figure 20. Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Sexual Dysfunction Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Sexual Dysfunction Drugs Sales Market Share by Type in 2019
Figure 23. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Sexual Dysfunction Drugs Revenue Market Share by Type in 2019
Figure 25. Global Sexual Dysfunction Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Sexual Dysfunction Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Sexual Dysfunction Drugs Sales Market Share by Application in 2019
Figure 28. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Sexual Dysfunction Drugs Revenue Market Share by Application in 2019
Figure 30. North America Sexual Dysfunction Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Sexual Dysfunction Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Sexual Dysfunction Drugs Sales Market Share by Country in 2019
Figure 33. North America Sexual Dysfunction Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Sexual Dysfunction Drugs Market Share by Type in 2019
Figure 39. North America Sexual Dysfunction Drugs Market Share by Application in 2019
Figure 40. Europe Sexual Dysfunction Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Sexual Dysfunction Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Sexual Dysfunction Drugs Sales Market Share by Country in 2019
Figure 43. Europe Sexual Dysfunction Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Sexual Dysfunction Drugs Market Share by Type in 2019
Figure 55. Europe Sexual Dysfunction Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Sexual Dysfunction Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Sexual Dysfunction Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Sexual Dysfunction Drugs Revenue Market Share by Region in 2019
Figure 60. China Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Sexual Dysfunction Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Sexual Dysfunction Drugs Market Share by Application in 2019
Figure 84. Latin America Sexual Dysfunction Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Sexual Dysfunction Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Sexual Dysfunction Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Sexual Dysfunction Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Sexual Dysfunction Drugs Market Share by Type in 2019
Figure 95. Latin America Sexual Dysfunction Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Sexual Dysfunction Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Sexual Dysfunction Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Sexual Dysfunction Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Sexual Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Sexual Dysfunction Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Sexual Dysfunction Drugs Market Share by Application in 2019
Figure 108. North America Sexual Dysfunction Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Sexual Dysfunction Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Sexual Dysfunction Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Sexual Dysfunction Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Sexual Dysfunction Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Sexual Dysfunction Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Sexual Dysfunction Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Sexual Dysfunction Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Sexual Dysfunction Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Sexual Dysfunction Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
女性用性的欲求低下障害（HSDD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Female …- 勃起不全（ED）の世界市場（～2026年） The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The ED drugs segment led the market and accounted for almost 80% of the market share in terms of…
- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 勃起不全衝撃波発生器の世界市場（～2026年） Market Analysis and Insights: Global Erectile Dysfunction Shockwave Generators Market The global Erectile Dysfunction Shockwave Generators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Erectile Dysfunction Shockwave …